Industry Insight | Novo Nordisk Expands Diabetes Cell Therapy Partnership with Aspect Biosystems
January 25, 2026 — Global Biotech NewsCopenhagen, Denmark / Vancouver, Canada — Danish pharmaceutical giant Novo Nordisk A/S has announced an expansion of its strategic collaboration with Canadian...
More+
Industry Insight | Sarepta Reports Positive Three-Year Data for Duchenne Gene Therapy Elevidys
January 2026Sarepta Therapeutics announced new three-year follow-up data showing that its Duchenne muscular dystrophy (DMD) gene therapy Elevidys (delandistrogene moxeparvovec) continued to demonstrat...
More+
Industry Insight | FDA Officials Recommend Long-Term Follow-Up for CAR-T Therapies in Autoimmune Diseases
February 2, 2026 — Global Biotech NewsSilver Spring, MD, USA — Senior officials at the U.S. Food and Drug Administration (FDA) have urged biotechnology companies to implement long-term monitoring of...
More+
Industry Insight | FDA Clears IND for AAV-Based Gene Therapy Targeting High-Grade Glioma
February 2026 — Global Biotech NewsSan Francisco, CA / USA — The U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for SRN-101, an AAV-based immuno-ge...
More+
Industry Insight | Global Cell & Gene Therapy Industry Shows Strong Growth Across Approvals, Revenue and Deals
February 2026 — Industry NewsThe global cell and gene therapy (CGT) sector continues to expand, with recent industry data highlighting a combination of strong product revenues, increasing regulatory ...
More+
Industry Insight | CARsgen Administers First Dose of Allogeneic CAR-T Therapy to Patient With Systemic Lupus Erythematosus
February 2026 — Global Biotech NewsShanghai, China / Global — CARsgen Therapeutics Holdings Ltd., a clinical-stage biotechnology company focused on innovative chimeric antigen receptor T-cell (CAR-T...
More+
Industry Insight | Historic Breakthrough! The World's First iPSC Cell Therapy Products Approved in Japan
On February 19, 2026, Japan's Ministry of Health, Labour and Welfare (MHLW) granted conditional and time-limited approval to the world's first two induced pluripotent stem cell (iPSC)–based r...
More+